Vaccines
Feature
Polio: Five African countries vaccinating 23 million children
News from the FDA/CDC
As FDA OKs another COVID booster, some experts question need
“Is the goal to prevent any symptomatic infection with COVID-19, is the goal to prevent the spread of COVID-19, or is the goal to prevent severe...
Conference Coverage
Aluminum named allergen of the year
Reactions normally present as itchy nodules that can last for months and even years.
Feature
Natural, vaccine-induced, and hybrid immunity to COVID-19
Latest News
Moderna reports positive COVID-19 vaccine response in kids down to 6 months
Vaccine efficacy against infection was 43.7% in children aged 6 months to 2 years and 37.5% among children aged 2-6 years, the new data from its...
Letters from Maine
Waiting for the under-5 COVID-19 vaccine
This may be yet another instance of when the crafty COVID-19 has moved with a pace that will make an under–age-5 vaccine of relatively little...
From the Journals
Babies of pregnant women who get RSV vaccine likely to be prescribed fewer antimicrobials
Conference Coverage
Norovirus vaccine candidates employ different approaches
From the Journals
‘Overwhelming’ need to study COVID vaccine–associated tinnitus
From the Journals
COVID-19 often more severe with congenital heart defects
“Hospitalized patients with heart defects are up to twice as likely to have critical outcomes of COVID-19 illness,” says author of a new study.
From the Journals
Double-dose COVID-19 vaccines showed limited effectiveness against Omicron
“For now, we are going to have to realize that it is virtually impossible to prevent mild COVID without frequent boosting.”